|
KMID : 1144820210270040329
|
|
대한의생명과학회지
2021 Volume.27 No. 4 p.329 ~ p.333
|
|
|
CD8-dependent Tumor Growth Inhibition by Tumor Cells Genetically Modified with 4-1BBL
|
|
Kim Hong-Sung
|
|
|
Abstract
|
|
|
|
We previously identified that tumor cells genetically modified with a 4-1BBL co-stimulatory molecule had anticancer effects in a CT26 mouse colorectal tumor model. To identify the distinction between immune cells in a mouse tumor model treated with tumor cells genetically modified with 4-1BBL or β-gal, we examined the immune cells in CT26-WT, CT26-βgal, and CT26-4-1BBL tumor bearing mice 21 days after tumor cell administration. The CD8+ T cells population in mice treated with tumor cells genetically modified with 4-1BBL was significantly increased on day 21 compared to that of tumor cells genetically modified with β-gal in the spleen and tumor tissue. The CD4+ T cell population was not different between the two mice groups. The Foxp3+CD25high CD4 T cell population decreased on day 21 in tumor tissues, but the decrease was not significant. We also found that CD8 T cells had pivotal roles in inhibiting tumor growth by treating mice with ant-CD4 and CD8 antibodies. These results suggest that tumor cells genetically modified with 4-1BBL could inhibit tumor growth by affecting on CD8 T lymphocytes.
|
|
|
KEYWORD
|
|
|
CD8 T cells, Regulatory T cells, Tumor growth inhibition, 4-1BBL
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|